 Home > Active Ingredient News > Antitumor Therapy > JAMA Oncol: Analysis of related factors of treatment regret in local prostate cancer patients

JAMA Oncol: Analysis of related factors of treatment regret in local prostate cancer patients

 Last Update: 2021-12-24
 Source: Internet
 Author: User

Tags

superior water treatment

stage 1 lung cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Treatment regret is a comprehensive, patient-centered measurement involving morbidity, oncology results, and anxiety related to the diagnosis and treatment of prostate cancer
.

Recently, researchers from the United States published an article in the "JAMA Oncol" magazine, evaluating the treatment of local prostate cancer patients, functional outcomes, and the relationship between patient expectations and treatment regrets
.

Evaluated the treatment methods, functional outcomes, and the relationship between patient expectations and treatment regrets in patients with localized prostate cancer

The study is based on population and is a prospective cohort study
.

Participants included men with clinically localized prostate cancer from January 1, 2011 to December 31, 2012.

The main result is the treatment-related regret reported by the patient

In addition, there is a clear relationship between sexual dysfunction and regret (aOR, 0.
65 [95% CI, 0.
52-0.
81])
.

Compared with the patient’s expectations before treatment, the treatment effect (aOR, 5.

The relationship between regrets reported by patients and treatment

In summary, the results of this cohort study show that out of every 10 patients with localized prostate cancer, at least one has treatment-related regrets
.

The regret rate of different treatments seems to be different and is mediated by functional outcomes and patient expectations

In every 10 patients with localized prostate cancer, at least one has treatment-related regrets

Original source:

Christopher JD Wallis, Zhiguo Zhao, Li-Ching Huang et al.

Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.